The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-butyl-N,N-dimethyl-8-(thiophen-2-yl)-2-azaspiro[4.5]decan-8-amine ID: ALA4476510
PubChem CID: 118662291
Max Phase: Preclinical
Molecular Formula: C19H32N2S
Molecular Weight: 320.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCN1CCC2(CCC(c3cccs3)(N(C)C)CC2)C1
Standard InChI: InChI=1S/C19H32N2S/c1-4-5-13-21-14-12-18(16-21)8-10-19(11-9-18,20(2)3)17-7-6-15-22-17/h6-7,15H,4-5,8-14,16H2,1-3H3
Standard InChI Key: JZDAXBWFVCWENT-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
11.1848 -2.8106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5893 -3.5164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3982 -3.5190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8088 -2.8175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4043 -2.1117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5893 -2.1075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6403 -2.1943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8852 -2.5215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9630 -3.3409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7663 -3.5199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3846 -2.2328 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1755 -2.4383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1671 -1.4451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3846 -3.3926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3504 -3.8817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5757 -3.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9631 -4.1623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1884 -3.9021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2578 -4.1964 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.9831 -4.5654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5583 -3.9896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1883 -3.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 1 1 0
4 11 1 0
11 12 1 0
11 13 1 0
4 14 1 0
9 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
14 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 14 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 320.55Molecular Weight (Monoisotopic): 320.2286AlogP: 4.57#Rotatable Bonds: 5Polar Surface Area: 6.48Molecular Species: BASEHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.35CX LogP: 4.42CX LogD: -0.16Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.78Np Likeness Score: -1.10
References 1. Rosse G.. (2016) Treatment of Pain with Spirocylic Cyclohexane Derivatives Having Dual Specificity for ORL-1 and μ-Opioid Receptors., 7 (9): [PMID:27660683 ] [10.1021/acsmedchemlett.6b00277 ]